AAgilent Technologies

Health care · Lab Instruments · NYSE

A and 9 peers, year by year

The 9 Health care companies closest to A in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
A Agilent Technologies	FY2025	$6.9B	+6.7%	-	21.3%	18.8%	16.6%	19.3%	0.50
EW Edwards Lifesciences	FY2025	$6.1B	+11.5%	78.0%	20.8%	17.7%	22.0%	10.4%	0.06
SOLV Solventum	FY2025	$8.3B	+0.9%	53.5%	26.2%	18.7%	−0.1%	30.8%	1.00
ZBH Zimmer Biomet	FY2025	$8.2B	+7.2%	-	13.3%	8.6%	17.9%	5.6%	0.59
STE Steris	FY2026	$5.9B	+8.7%	44.2%	18.6%	13.2%	16.4%	10.9%	0.27
INCY Incyte	FY2025	$5.1B	+21.2%	-	29.5%	25.0%	-	24.9%	-
RMD ResMed	FY2026	$5.7B	+9.9%	61.1%	33.4%	26.9%	29.2%	23.1%	0.10
ZTS Zoetis	FY2025	$9.5B	+2.3%	-	-	28.2%	24.1%	78.3%	2.65
DXCM Dexcom	FY2025	$4.7B	+15.6%	60.1%	19.6%	17.9%	23.1%	30.5%	-
IDXX Idexx Laboratories	FY2025	$4.3B	+10.4%	61.8%	31.6%	24.6%	24.6%	66.0%	0.28

Revenuepeer median $5.9B

Sales growthpeer median +9.9%

Gross marginpeer median 60.6%

EW 78.0%
IDXX 61.8%
RMD 61.1%
DXCM 60.1%
SOLV 53.5%
STE 44.2%
A -
ZBH -
INCY -
ZTS -

Operating marginpeer median 23.5%

Net marginpeer median 18.7%

FCF marginpeer median 22.6%

Return on equitypeer median 24.9%

Debt / equitypeer median 0.28

ZTS 2.65
SOLV 1.00
ZBH 0.59
A 0.50
IDXX 0.28
STE 0.27
RMD 0.10
EW 0.06
INCY -
DXCM -

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	$4.2B	$4.5B	$4.9B	$5.2B	$5.3B	$6.3B	$6.8B	$6.8B	$6.5B	$6.9B
EW Dec	$3.0B	$3.4B	$3.7B	$4.3B	$4.4B	$5.2B	$4.5B	$5.0B	$5.4B	$6.1B
SOLV Dec	-	-	-	-	-	-	$8.1B	$8.2B	$8.3B	$8.3B
ZBH Dec	$7.7B	$7.8B	$7.9B	$8.0B	$6.1B	$6.8B	$6.9B	$7.4B	$7.7B	$8.2B
STE Mar	-	$2.6B	$2.6B	$2.8B	$3.0B	$3.1B	$4.2B	$4.5B	$5.1B	$5.5B
INCY Dec	$1.1B	$1.5B	$1.9B	$2.2B	$2.7B	$3.0B	$3.4B	$3.7B	$4.2B	$5.1B
RMD Jun	$1.8B	$2.1B	$2.3B	$2.6B	$3.0B	$3.2B	$3.6B	$4.2B	$4.7B	$5.1B
ZTS Dec	$4.9B	$5.3B	$5.8B	$6.3B	$6.7B	$7.8B	$8.1B	$8.5B	$9.3B	$9.5B
DXCM Dec	$573.3M	$718.5M	$1.0B	$1.5B	$1.9B	$2.4B	$2.9B	$3.6B	$4.0B	$4.7B
IDXX Dec	$1.8B	$2.0B	$2.2B	$2.4B	$2.7B	$3.2B	$3.4B	$3.7B	$3.9B	$4.3B
Peer median	$1.8B	$2.3B	$2.5B	$2.7B	$3.0B	$3.2B	$4.2B	$4.5B	$5.1B	$5.5B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	+4.1%	+6.4%	+9.9%	+5.1%	+3.4%	+18.4%	+8.4%	−0.2%	−4.7%	+6.7%
EW Dec	+18.8%	+15.9%	+8.4%	+16.8%	+0.9%	+19.3%	+2.9%	+12.2%	+8.6%	+11.5%
SOLV Dec	-	-	-	-	-	-	-	+0.8%	+0.7%	+0.9%
ZBH Dec	+27.9%	+1.8%	+1.7%	+0.6%	−12.0%	+11.4%	+1.6%	+6.5%	+3.8%	+7.2%
STE Mar	-	-	+0.3%	+6.2%	+8.9%	+2.5%	+47.5%	+7.4%	+13.3%	+6.2%
INCY Dec	+46.7%	+38.9%	+22.5%	+14.7%	+23.5%	+12.0%	+13.7%	+8.9%	+14.8%	+21.2%
RMD Jun	-	+12.4%	+13.2%	+11.4%	+13.4%	+8.1%	+11.9%	+18.0%	+10.9%	+9.8%
ZTS Dec	+2.6%	+8.6%	+9.8%	+7.5%	+6.6%	+16.5%	+3.9%	+5.7%	+8.3%	+2.3%
DXCM Dec	+42.6%	+25.3%	+43.6%	+43.1%	+30.5%	+27.1%	+18.8%	+24.5%	+11.3%	+15.6%
IDXX Dec	+10.8%	+10.9%	+12.4%	+8.8%	+12.5%	+18.8%	+4.7%	+8.7%	+6.5%	+10.4%
Peer median	+23.4%	+12.4%	+11.1%	+10.1%	+10.7%	+14.2%	+8.3%	+8.7%	+8.6%	+9.8%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	-	-	-	-	-	-	-	-	-	-
EW Dec	73.1%	74.5%	74.8%	74.4%	75.4%	76.1%	83.8%	80.5%	79.5%	78.0%
SOLV Dec	-	-	-	-	-	-	57.7%	57.3%	55.6%	53.5%
ZBH Dec	-	-	-	-	-	-	-	-	-	-
STE Mar	-	39.3%	41.7%	42.2%	43.6%	43.2%	44.6%	43.7%	43.2%	44.0%
INCY Dec	-	-	-	-	-	-	-	-	-	-
RMD Jun	58.0%	58.1%	57.0%	57.3%	58.1%	57.5%	56.6%	55.8%	56.7%	59.4%
ZTS Dec	-	-	-	-	-	-	-	-	-	-
DXCM Dec	66.0%	68.5%	64.4%	63.1%	66.4%	68.6%	64.7%	63.2%	60.5%	60.1%
IDXX Dec	54.9%	55.7%	56.1%	56.7%	58.0%	58.8%	59.5%	59.8%	61.0%	61.8%
Peer median	62.0%	58.1%	57.0%	57.3%	58.1%	58.8%	58.6%	58.5%	58.6%	59.7%

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	14.6%	18.0%	18.4%	18.2%	15.8%	21.3%	23.6%	19.8%	22.9%	21.3%
EW Dec	25.3%	31.7%	20.1%	26.4%	20.5%	32.3%	33.6%	26.1%	25.3%	20.8%
SOLV Dec	-	-	-	-	-	-	20.8%	20.6%	12.6%	26.2%
ZBH Dec	10.7%	10.2%	0.4%	14.3%	1.4%	12.6%	10.0%	17.3%	16.7%	13.3%
STE Mar	-	8.7%	15.3%	14.8%	17.7%	17.6%	11.3%	17.4%	16.3%	15.9%
INCY Dec	13.1%	−15.8%	6.9%	18.6%	−9.9%	19.6%	17.1%	16.8%	1.4%	29.5%
RMD Jun	23.3%	20.6%	23.2%	22.2%	27.4%	28.3%	28.0%	26.8%	28.2%	32.7%
ZTS Dec	-	-	-	-	-	-	-	-	-	-
DXCM Dec	−11.1%	−5.9%	−18.1%	9.6%	15.5%	10.9%	13.4%	16.5%	14.9%	19.6%
IDXX Dec	19.7%	21.0%	22.2%	23.0%	25.7%	29.0%	26.7%	30.0%	29.0%	31.6%
Peer median	16.4%	10.2%	15.3%	18.6%	17.7%	19.6%	18.9%	19.0%	16.5%	23.5%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	11.0%	15.3%	6.4%	20.7%	13.5%	19.1%	18.3%	18.1%	19.8%	18.8%
EW Dec	19.2%	17.0%	19.4%	24.1%	18.8%	28.7%	34.1%	28.0%	76.7%	17.7%
SOLV Dec	-	-	-	-	-	-	16.5%	16.4%	5.8%	18.7%
ZBH Dec	4.0%	23.2%	−4.8%	14.2%	−2.3%	5.9%	3.3%	13.8%	11.8%	8.6%
STE Mar	-	4.2%	11.1%	10.9%	13.5%	12.8%	5.8%	2.4%	7.4%	11.3%
INCY Dec	9.4%	−20.4%	5.8%	20.7%	−11.1%	31.8%	10.0%	16.2%	0.8%	25.0%
RMD Jun	19.2%	16.6%	13.5%	15.5%	21.0%	14.8%	21.8%	21.3%	21.8%	27.2%
ZTS Dec	16.8%	16.3%	24.5%	24.0%	24.5%	26.2%	26.2%	27.4%	26.9%	28.2%
DXCM Dec	−11.4%	−7.0%	−12.3%	6.8%	28.5%	8.9%	11.7%	14.9%	14.3%	17.9%
IDXX Dec	12.5%	13.4%	17.0%	17.8%	21.5%	23.2%	20.2%	23.1%	22.8%	24.6%
Peer median	12.5%	14.8%	12.3%	16.6%	19.9%	19.0%	16.5%	16.4%	14.3%	18.7%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	$654.0M	$713.0M	$910.0M	$866.0M	$802.0M	$1.3B	$1.0B	$1.5B	$1.4B	$1.2B
EW Dec	$528.3M	$832.6M	$688.0M	$928.5M	$647.3M	$1.4B	$973.6M	$642.8M	$289.9M	$1.3B
SOLV Dec	-	-	-	-	-	-	$1.4B	$1.6B	$805.0M	−$10.0M
ZBH Dec	$1.4B	$1.4B	$1.6B	$1.4B	$1.1B	$1.4B	$1.2B	$1.3B	$1.3B	$1.5B
STE Mar	-	$251.2M	$292.2M	$349.8M	$376.0M	$450.4M	$397.2M	$395.0M	$613.0M	$778.0M
INCY Dec	$184.5M	−$204.0M	$262.7M	$632.6M	−$312.0M	$568.5M	$892.1M	-	-	-
RMD Jun	$489.4M	$351.8M	$442.4M	$390.3M	$706.9M	$634.0M	$216.3M	$573.6M	$1.3B	$1.7B
ZTS Dec	$497.0M	$1.1B	$1.5B	$1.3B	$1.7B	$1.7B	$1.3B	$1.6B	$2.3B	$2.3B
DXCM Dec	$500K	$26.0M	$56.1M	$134.5M	$276.6M	$53.3M	$304.7M	$511.9M	$630.7M	$1.1B
IDXX Dec	$274.2M	$298.9M	$284.3M	$304.2M	$541.1M	$636.0M	$394.1M	$772.9M	$808.1M	$1.1B
Peer median	$489.4M	$325.4M	$367.3M	$511.5M	$594.2M	$635.0M	$892.1M	$707.8M	$806.5M	$1.2B

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	15.6%	15.9%	18.5%	16.8%	15.0%	20.5%	14.9%	21.6%	21.1%	16.6%
EW Dec	17.8%	24.2%	18.5%	21.4%	14.8%	26.9%	21.8%	12.8%	5.3%	22.0%
SOLV Dec	-	-	-	-	-	-	17.6%	19.8%	9.8%	−0.1%
ZBH Dec	18.9%	18.3%	20.0%	17.3%	17.8%	19.9%	16.8%	17.5%	16.9%	17.9%
STE Mar	-	9.6%	11.2%	12.6%	12.4%	14.5%	9.4%	8.7%	11.9%	14.3%
INCY Dec	16.7%	−13.3%	14.0%	29.3%	−11.7%	19.0%	26.3%	-	-	-
RMD Jun	26.6%	17.0%	18.9%	15.0%	23.9%	19.8%	6.0%	13.6%	27.8%	32.3%
ZTS Dec	10.2%	21.1%	24.9%	21.3%	25.1%	22.3%	16.4%	19.0%	24.8%	24.1%
DXCM Dec	0.1%	3.6%	5.4%	9.1%	14.4%	2.2%	10.5%	14.1%	15.6%	23.1%
IDXX Dec	15.4%	15.2%	12.8%	12.6%	20.0%	19.8%	11.7%	21.1%	20.7%	24.6%
Peer median	16.7%	16.1%	16.2%	16.1%	16.3%	19.8%	16.4%	15.8%	16.3%	22.6%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	10.9%	14.2%	6.9%	22.6%	14.8%	22.5%	23.6%	21.2%	21.9%	19.3%
EW Dec	21.7%	19.7%	23.0%	25.2%	18.0%	25.8%	26.2%	21.1%	41.8%	10.4%
SOLV Dec	-	-	-	-	-	-	11.4%	11.5%	16.2%	30.8%
ZBH Dec	3.2%	15.5%	−3.4%	9.1%	−1.1%	3.2%	1.9%	8.2%	7.2%	5.6%
STE Mar	-	3.9%	9.1%	9.6%	12.0%	10.2%	3.7%	1.8%	6.0%	9.3%
INCY Dec	24.8%	−19.2%	5.7%	17.2%	−11.3%	25.2%	7.8%	11.5%	0.9%	24.9%
RMD Jun	20.8%	17.5%	15.3%	19.5%	24.9%	16.4%	23.2%	21.7%	21.0%	23.5%
ZTS Dec	55.2%	48.8%	65.4%	55.4%	43.5%	44.8%	48.0%	46.9%	52.1%	78.3%
DXCM Dec	−23.1%	−12.0%	−19.2%	11.5%	35.4%	10.6%	16.0%	26.2%	27.4%	30.5%
IDXX Dec	n/m	n/m	n/m	n/m	92.0%	107.9%	111.6%	56.9%	55.7%	66.0%
Peer median	21.3%	15.5%	9.1%	17.2%	21.4%	20.8%	16.0%	21.1%	21.0%	24.9%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	0.44	0.41	0.39	0.51	0.48	0.51	0.52	0.47	0.57	0.50
EW Dec	0.31	0.35	0.19	0.14	0.13	0.10	0.10	0.09	0.06	0.06
SOLV Dec	-	-	-	-	-	-	-	0.00	2.71	1.00
ZBH Dec	1.16	0.86	0.79	0.66	0.67	0.08	0.47	0.46	0.50	0.59
STE Mar	-	-	0.41	0.37	0.34	0.43	0.47	0.51	0.51	0.31
INCY Dec	1.79	0.02	9.91	-	-	-	-	-	-	-
RMD Jun	0.69	0.55	0.14	0.61	0.47	0.23	0.23	0.35	0.15	0.11
ZTS Dec	3.00	2.80	2.95	2.38	1.91	1.45	1.79	1.31	1.38	2.65
DXCM Dec	-	-	-	-	-	-	-	-	-	-
IDXX Dec	n/m	n/m	n/m	3.94	1.44	1.23	1.26	0.47	0.39	0.28
Peer median	1.16	0.55	0.60	0.64	0.57	0.33	0.47	0.46	0.50	0.31

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
A Oct	$1.40	$2.10	$0.97	$3.37	$2.30	$3.94	$4.18	$4.19	$4.43	$4.57
EW Dec	$0.87	$0.90	$1.13	$1.64	$1.30	$2.38	$2.44	$2.30	$6.97	$1.83
SOLV Dec	-	-	-	-	-	-	$7.78	$7.79	$2.76	$8.88
ZBH Dec	$1.51	$8.90	−$1.86	$5.47	−$0.67	$1.91	$1.10	$4.88	$4.43	$3.55
STE Mar	-	$1.28	$3.39	$3.55	$4.76	$4.63	$2.48	$1.07	$3.81	$6.20
INCY Dec	$0.54	−$1.53	$0.51	$2.05	−$1.36	$4.27	$1.52	$2.65	$0.15	$6.41
RMD Jun	$2.49	$2.40	$2.19	$2.80	$4.27	$3.24	$5.30	$6.09	$6.92	$9.51
ZTS Dec	$1.65	$1.75	$2.93	$3.11	$3.42	$4.27	$4.49	$5.07	$5.47	$6.02
DXCM Dec	−$0.78	−$0.58	−$1.44	$1.10	$1.33	$0.53	$0.82	$1.30	$1.42	$2.09
IDXX Dec	$2.44	$2.94	$4.26	$4.89	$6.71	$8.60	$8.03	$10.06	$10.67	$13.08
Peer median	$1.51	$1.52	$1.66	$2.96	$2.38	$3.75	$2.48	$4.88	$4.43	$6.20

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out A and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on A in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/A/export.csv") into a cell.